| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 86221 |
带有DBCO的麦芽三糖, Glcα1-4Glcα1-4Glc-O-(CH2)3-NH-DBCO |
140 |
kx |
2024-12-13 |
| 86222 |
Glcβ1-4[Glcβ1-4]3Glc-O-(CH2)3-NH2.HCl ,具有游离末端胺(接头-NH2 A)的纤维二糖 |
138 |
kx |
2024-12-13 |
| 86223 |
Glcβ1-4[Glcβ1-4]2Glc-O-(CH2)3-NH-DBCO ,含DBCO的纤维四糖(接头-DBCO A) |
196 |
kx |
2024-12-13 |
| 86224 |
DOTA-CH2-Ph-azide(HCl salt),DOTA螯合剂 |
176 |
h |
2024-12-13 |
| 86225 |
Glcβ1-4Glc-O-(CH2)3-NH-DBCO , 含DBCO的纤维二糖(接头-DBCO A) |
192 |
kx |
2024-12-13 |
| 86226 |
DOTA-DBCO双功能螯合剂 |
157 |
h |
2024-12-13 |
| 86227 |
Glcβ1-4Glcβ1-4Glc-O-(CH2)3-NH-DBCO , 含DBCO的纤维三糖(接头-DBCO A) |
167 |
kx |
2024-12-13 |
| 86228 |
DOTA-(COOt-Bu)3-NHS,CAS:819869-77-7 |
136 |
h |
2024-12-13 |
| 86229 |
GlcNAcβ1-3Gal与生物素和硬脂酸链相连(接头-BT-STEA A) |
201 |
kx |
2024-12-13 |
| 86230 |
棕榈酸-酮缩硫醇-羧酸,C16-TK-COOH |
186 |
wyh |
2024-12-13 |
| 86231 |
DOTA-(COOt-Bu)3-C2-NH2,CAS:173308-19-5 |
156 |
h |
2024-12-13 |
| 86232 |
Methyltetrazine-PEG5-CO-piperazine-C3-Mal的应用领域 |
179 |
kx |
2024-12-13 |
| 86233 |
DO-(CH2COOt-Bu)2,环状多胺多羧类配体,CAS:162148-48-3 |
168 |
h |
2024-12-13 |
| 86234 |
4,7,10-TRI-(T-BUTYLOXYCARBONYLMETHYL) |
110 |
h |
2024-12-13 |
| 86235 |
carboxymethyl-dextran-A2-gadolinium-DOTA |
136 |
h |
2024-12-13 |
| 86236 |
Tat-DOTA,DOTA-TAT(48-60),DOTA偶联细胞穿膜肽TAT |
214 |
h |
2024-12-13 |
| 86237 |
Cl-C6-PEG4-NHCO-C3-NHS,氯-C6--四聚乙二醇-酰胺-C3-琥珀酰亚胺酯 |
180 |
kx |
2024-12-13 |
| 86238 |
dysprosium-DOTA-PAMAM |
156 |
h |
2024-12-13 |
| 86239 |
Cl-C6-PEG3-NHCO-C3-NHS,氯-C6--三聚乙二醇-酰胺-C3-琥珀酰亚胺酯 |
210 |
kx |
2024-12-13 |
| 86240 |
Y-DOTA-TOC,CAS:293295-66-6 |
158 |
h |
2024-12-13 |
| 86241 |
DOTA-MAL-Cys39-exendin-4 |
185 |
h |
2024-12-13 |
| 86242 |
DO3A叔丁酯,CAS: 122555-91-3 |
371 |
h |
2024-12-13 |
| 86243 |
1202761-21-4,Biotinyl-NH-PEG3-C3-amido-C3-COOH |
180 |
kx |
2024-12-13 |
| 86244 |
(m-PEG4)2-C-C3-Br |
168 |
kx |
2024-12-13 |
| 86245 |
1,1,4,4,7,7-六(1,1-二甲基乙基)10,10-[(5-硝基-1,3-苯基)双(亚甲基)]双[1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸酯 |
337 |
h |
2024-12-13 |
| 86246 |
二乙酰氧二辛基锡盐,CAS:17586-94-6 |
197 |
h |
2024-12-13 |
| 86247 |
二苯基环辛炔-聚乙二醇-大环配体 |
141 |
h |
2024-12-13 |
| 86248 |
Azide-PEG11-CH2CH2CH2-COOtBu,叠氮-十一聚乙二醇-C3-叔丁酯 |
177 |
kx |
2024-12-13 |
| 86249 |
(S)-4-(4-(3-((4-((2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL) |
193 |
h |
2024-12-13 |
| 86250 |
DOTA四乙酸酯,CAS: 825625-07-8 |
350 |
h |
2024-12-13 |
| 86251 |
Boc-NH-PEG7-C3-acid,氨基叔丁酯-七聚乙二醇-C3-酸 |
136 |
kx |
2024-12-13 |
| 86252 |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid |
174 |
h |
2024-12-13 |
| 86253 |
2731015-03-3,Boc-NH-PEG1-C3-acid,氨基叔丁酯-一聚乙二醇-C3-酸 |
159 |
kx |
2024-12-13 |
| 86254 |
Azide-PEG6-CH2CH2CH2-COOtBu,叠氮-六聚乙二醇-C3-叔丁酯 |
170 |
kx |
2024-12-13 |
| 86255 |
APN-C3-PEG5-acid, APN-C3-五聚乙二醇-羧酸 |
145 |
kx |
2024-12-13 |
| 86256 |
Pomalidomide-C3-NH2 hydrochloride的主要结构与功能基团 |
170 |
kx |
2024-12-13 |
| 86257 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, α-(2-carboxyethyl)-, 1,4,7,10-tetrakis(1,1-dimethylethyl)ester,(αR)- |
162 |
h |
2024-12-13 |
| 86258 |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid |
156 |
h |
2024-12-13 |
| 86259 |
Azide-C3-Iodoacetamide的应用领域 |
149 |
kx |
2024-12-13 |
| 86260 |
CAS: 1161883-51-7,Propargyl-PEG5-CH2CO2-NHS |
203 |
WYQ |
2024-12-13 |
| 86261 |
CAS: 1429934-37-1,Propargyl-PEG5-CH2CO2H |
128 |
WYQ |
2024-12-13 |
| 86262 |
CAS:1610950-41-8,DOTA-甲基四嗪 |
133 |
h |
2024-12-13 |
| 86263 |
CAS: 1694731-93-5,Propargyl-PEG4-CH2CO2H |
109 |
WYQ |
2024-12-13 |
| 86264 |
CAS: 141282-35-1,Amino-PEG5-CH2CO2H(氨基-五聚乙二醇-乙酸) |
153 |
WYQ |
2024-12-13 |
| 86265 |
2768332-86-9,FmocNH-C2-NHCO-PC-NHCO-C4-COOH,N-芴甲氧羰基-C2-酰胺-PC-酰胺-C4-羧酸 |
122 |
kx |
2024-12-13 |